Figures are based on lobbying activity reported to the Senate Office of Public Records. Reported dollar amounts are required to be accurate only to the nearest $20,000. For organizations whose primary business is lobbying, we display total income and top clients. For organizations that are not primarily lobbying firms, we display total amount spent on lobbying and top lobbying firms hired.
For more information, please see our lobbying methodology page.
Lobbying on Behalf of Scleroderma Foundation
Names of Lobbyists
Most Frequently Disclosed Lobbying Issues
- Fed Budget & Appropriations,
- Health Issues
Most Frequently Disclosed Bills
Bill No. Title H.R.1672 Scleroderma Research and Awareness Act of 2011 S.649 Scleroderma Research and Awareness Act H.R.2408 Scleroderma Research and Awareness Act of 2010 S.1545 Scleroderma Research and Awareness Act
RegulationsMentioned in 4 dockets
All data is based on documents downloaded from Regulations.gov. The first table shows mentions: all documents that include the name of the company anywhere in the document or document metadata. The second table shows submissions: all documents where the submitter metadata included the company name. Each table shows the top 10 dockets, ranked by number of occurrences.
Matches are based on a search for the company name. Variations in the company name, such as acronyms, nicknames or alternate names may cause documents to be missed. The mention of a company name in a document may be incidental and does not necessarily indicate that the company has any relevance to the document. Company names that are common English words may erroneously match with text that is not referring to the company.
Not all agencies submit public comments to Regulations.gov. For a list of participating and non-participating agencies see here. Agencies that do submit to Regulations.gov have varying levels of accuracy and completeness.
Regulations and public comments can be downloaded in bulk here.
The tables show occurrences of "Scleroderma Foundation" in public comments on proposed federal regulations.
Mentions in Document Text
View all mentions data for Scleroderma Foundation
- Toggle 1 NHTSA Environmental Impact Statement for Corporate Average Fuel Economy (CAFE)Standards, Model Years 2017-2025 2011
- Toggle 1 FDA Set Tolerance Levels for Polycyclic Aromatic Hydrocarbons in Seafood 2011
- Toggle 1 Control of Air Pollution From New Motor Vehicles: Tier 3 Motor Vehicle Emission and Fuel Standards 2011
- Toggle 1 Addition of ortho-Nitrotoluene; Community Right-to-Know Toxic Chemical Release Reporting 2012